Breaking News

U.S. Official Says JPMorgan, Four Other Banks Hit By Hackers
Tweet TWEET

Montagu, Ares Said to Mull $1.4 Billion Euromedic Sale

The private-equity backers of health-care services operator Euromedic International are considering a sale of the company, according to three people with knowledge of the matter.

Euromedic has attracted interest from buyout firms and the company’s owners, including Ares Life Sciences and Montagu Private Equity LLP, could raise about 1 billion euros ($1.39 billion) from a sale, said the people, who asked not to be identified because the talks are private. A sales adviser hasn’t been hired, the people said.

The company, with its operational headquarters in Budapest, Hungary, provides services across Europe including diagnostic imaging, renal care and dialysis, clinical laboratory and radiotherapy services according to Montagu’s website. In 2011, Fresenius Medical Care AG & Co. (FME) bought Euromedic’s dialysis-services business in a deal valued at 485 million euros.

Montagu, Ares and Merrill Lynch Global Private Equity acquired Euromedic from Warburg Pincus LLC and GE Capital Equity Investments in 2008, according to Euromedic’s website.

Officials for Montagu and Ares declined to comment, while representatives for Euromedic and North Cove Partners, formerly Merrill Lynch Global Private Equity, didn’t respond to e-mailed requests seeking comment.

To contact the reporter on this story: Kiel Porter in London at kporter17@bloomberg.net

To contact the editors responsible for this story: Edward Evans at eevans3@bloomberg.net Jon Menon, Steve Bailey

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.